Focal One offers the leading choice for patients deciding between active surveillance and radical therapy who want a non-invasive option for prostate cancer management.
Providence St. John’s Cancer Institute’s team is committed to providing the most advanced care for prostate cancer patients. They believe in harnessing the latest technology to improve patient outcomes and recovery. In 2018 they introduced Focal One Robotic Focal HIFU to their treatment offerings. This revolutionary option offers new hope by allowing patients to preserve their sexual function and urinary control while quickly returning to normal activities.
Prisma Health formed a dedicated team committed to transforming prostate cancer care. They introduced Focal One Robotic Focal HIFU to Greenville, South Carolina, a groundbreaking treatment that offers new hope to patients. Their passion for advancing medical science and caring for each patient’s journey reflects a true story of hope, innovation, and compassionate care that continues to inspire and transform lives.
The dedicated team at Erlanger Health genuinely cares about prostate cancer patients. They use the innovative Focal One® HIFU Robotic System, which employs advanced high-intensity focused ultrasound (HIFU) technology. Through this technology, Erlanger Health strives to provide compassionate care and hope for those fighting prostate cancer, helping patients achieve the best possible outcomes with minimal impact on their lives.
At Hoag Family Cancer Institute, there’s a story of hope and innovation. Men facing prostate cancer no longer have to choose between fighting the disease and maintaining their quality of life. Hoag’s dedicated team introduced Focal One Robotic HIFU to Orange County, California. Their unwavering passion for science and compassionate care continues to inspire patients, transforming lives and offering new hope for a brighter future for prostate cancer patients.
A new chapter in prostate cancer patient care is beginning at the ROC Clinic in Madrid. The clinic is thrilled to introduce Focal One to Spain, empowering its team with advanced imaging technology. With this innovative tool integrated into its prostate cancer treatment plan, the clinic can now offer patients more precise and targeted therapies, bringing hope and personalized care to those in need.
The Urology Clinic at Cruz Vermelha Hospital in Lisbon, Portugal, is at the forefront of prostate cancer care. It offers Non-invasive, Non-Radical Focal One treatment, which stands out for its extreme precision, reliability, and improvement in patients’ quality of life.
The Focal One® HIFU Robotic System uses high performance, high intensity focused ultrasound (HIFU) technology that allows for precise targeting and destruction of part of the prostate, sparing healthy surrounding tissue and minimizing side effects. This non-invasive HIFU prostate treatment reduces the risk of complications often associated with other treatment options.
The Focal One® HIFU Robotic System uses high performance, high intensity focused ultrasound (HIFU) technology that allows for precise targeting and destruction of part of the prostate, sparing healthy surrounding tissue and minimizing side effects. This non-invasive HIFU prostate treatment reduces the risk of complications often associated with other treatment options.
Why Physicians are Adding Focal One to their Prostate Cancer Management Programs and how Focal HIFU Therapy fills an important gap in Prostate Cancer management programs. Visit the Physician section to review 154 peer-reviewed publications regarding Focal HIFU Therapy.